Adedayo A. Onitilo

6.1k total citations · 2 hit papers
167 papers, 3.7k citations indexed

About

Adedayo A. Onitilo is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Adedayo A. Onitilo has authored 167 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Oncology, 33 papers in Surgery and 32 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Adedayo A. Onitilo's work include Global Cancer Incidence and Screening (22 papers), Breast Cancer Treatment Studies (19 papers) and Cancer Treatment and Pharmacology (14 papers). Adedayo A. Onitilo is often cited by papers focused on Global Cancer Incidence and Screening (22 papers), Breast Cancer Treatment Studies (19 papers) and Cancer Treatment and Pharmacology (14 papers). Adedayo A. Onitilo collaborates with scholars based in United States, Australia and Nigeria. Adedayo A. Onitilo's co-authors include Jessica M. Engel, Suhail A.R. Doi, Rachel V. Stankowski, Bickol N. Mukesh, Robert T. Greenlee, Erin J. Aiello Bowles, Heather Spencer Feigelson, Ingrid Glurich, Laurence E. McCahill and Tom Barney and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Adedayo A. Onitilo

151 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Breast Cancer Subtypes Based on ER/PR and Her2 Expression: Comparison of Clinicopathologic Features and Survival

2009 585 citations Adedayo A. Onitilo, Jessica M. Engel et al. profile →
Risk of Heart Failure in Breast Cancer Patients After Anthracycline and Trastuzumab Treatment: A Retrospective Cohort Study

2012 411 citations Erin J. Aiello Bowles, Robert Wellman et al. JNCI Journal of the National Cancer Institute profile →

Peers

Countries citing papers authored by Adedayo A. Onitilo

Since Specialization

Citations

This map shows the geographic impact of Adedayo A. Onitilo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adedayo A. Onitilo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adedayo A. Onitilo more than expected).

Fields of papers citing papers by Adedayo A. Onitilo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adedayo A. Onitilo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adedayo A. Onitilo. The network helps show where Adedayo A. Onitilo may publish in the future.

Co-authorship network of co-authors of Adedayo A. Onitilo

This figure shows the co-authorship network connecting the top 25 collaborators of Adedayo A. Onitilo. A scholar is included among the top collaborators of Adedayo A. Onitilo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adedayo A. Onitilo. Adedayo A. Onitilo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Bariatric metabolic surgery and cancer risk: Target trial emulation using iterative time distribution matching 2025 ·Biomolecules and Biomedicine ·Jazeel Abdulmajeed, Zumin Shi, Manar E. Abdel‐Rahman, (unknown), M Fasihul Alam, Mashael Al‐Shafai, Muhammad E. H. Chowdhury, Abdullah Shaito, Adedayo A. Onitilo, Suhail A.R. Doi	0
2	Dual anti-CTLA-4 and anti-PD-1 blockade in metastatic basal cell carcinoma 2025 ·npj Precision Oncology ·Sandip Pravin Patel, (unknown), Young Kwang Chae, Shiruyeh Schokrpur, Christopher D. Lao, Benjamin Powers, Adrienne I. Victor, Adedayo A. Onitilo, (unknown), Naoko Takebe, (unknown), Christine M. McLeod, (unknown), Elad Sharon, Megan Othus, (unknown), Charles D. Blanke, Razelle Kurzrock	1
3	Inhibition of FOXM1 Synergizes with BH3 Mimetics Venetoclax and Sonrotoclax in Killing Multiple Myeloma Cells through Repressing MYC Pathway 2025 ·Advanced Science ·Zhi Wen, Yidan Wang, (unknown), (unknown), (unknown), Terrie Kitchner, (unknown), Sung Hoon Kim, (unknown), (unknown), (unknown), (unknown), John A. Katzenellenbogen, Scott J. Hebbring, Benita S. Katzenellenbogen, Siegfried Janz, Adedayo A. Onitilo	0
4	Cancer Research Funding in Africa 2025 ·Communications Medicine ·(unknown), (unknown), (unknown), (unknown), (unknown), Adedayo A. Onitilo, Syed Nabeel Zafar	1
5	Nutritional impairment, psychological health and quality of life among older adults with advanced cancer: A secondary analysis of a randomized clinical trial 2024 ·Cancer Medicine ·(unknown), (unknown), (unknown), Derick R. Peterson, Richard F. Dunne, (unknown), Judith O. Hopkins, (unknown), Adedayo A. Onitilo, Valerie Targia, Supriya G. Mohile, Kah Poh Loh	2
6	Alisertib in patients with extensive-stage small-cell lung cancer: The phase 2 ALISCA-Lung1 study. 2024 ·Journal of Clinical Oncology ·Taofeek K. Owonikoko, Alberto Chiappori, Ryan D. Gentzler, Stephen V. Liu, Adedayo A. Onitilo, Nathan A. Pennell, Jacob Sands, Bo Wang, (unknown), Judith D. Bebchuk, Lisa D. Eli, Elaine K. Wong, Afshin Dowlati	1
7	Development and implementation of a 3d-HDR brachytherapy program for cervical cancer in a sub-Saharan African centre 2024 ·Brachytherapy ·(unknown), Onyinye Balogun, (unknown), Omolola Salako, Omoruyi Credit Irabor, (unknown), (unknown), (unknown), Ephraim Ohazurike, (unknown), (unknown), (unknown), Muhammad Habeebu, (unknown), Adedayo A. Onitilo, Wilfred Ngwa, Chika Nwachukwu	0
8	Concurrent Chemoradiation ± Atezolizumab (atezo) in Limited-Stage Small Cell Lung Cancer (LS-SCLC): Results of NRG Oncology/Alliance LU005 2024 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), Chengping Hu, Helen J. Ross, (unknown), David Kozono, (unknown), Elie G. Dib, (unknown), (unknown), (unknown), Adedayo A. Onitilo, (unknown), Xinan Wang, Rebecca Paulus, (unknown)	23
9	Phase II Study of Palbociclib in Patients with Tumors with CDK4 or CDK6 Amplification: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1C 2024 ·Clinical Cancer Research ·Mark H. O’Hara, Opeyemi A. Jegede, Mark A. Dickson, Angela DeMichele, Richard Piekarz, Robert J. Gray, Victoria Wang, Lisa M. McShane, Larry Rubinstein, David R. Patton, P. Mickey Williams, Stanley R. Hamilton, Adedayo A. Onitilo, James V. Tricoli, Barbara A. Conley, Carlos L. Arteaga, Lyndsay N. Harris, Peter J. O’Dwyer, Alice P. Chen, Keith T. Flaherty	1
10	Use of conditional estimates of effect in cancer epidemiology: An application to lung cancer treatment 2023 ·Cancer Epidemiology ·Jazeel Abdulmajeed, (unknown), (unknown), (unknown), (unknown), Jennifer Stone, Luis Furuya‐Kanamori, Adedayo A. Onitilo, Suhail A.R. Doi	1
11	E2112: Randomized Phase III Trial of Endocrine Therapy Plus Entinostat or Placebo in Hormone Receptor–Positive Advanced Breast Cancer. A Trial of the ECOG-ACRIN Cancer Research Group 2021 ·Journal of Clinical Oncology ·Roisín M. Connolly, Fengmin Zhao, Kathy D. Miller, Min-Jung Lee, Richard Piekarz, Karen L. Smith, Ursa Brown‐Glaberman, (unknown), Bryan A. Faller, Adedayo A. Onitilo, Mark E. Burkard, G. Thomas Budd, Ellis Levine, Melanie Royce, Peter A. Kaufman, Alexandra Thomas, Jane B. Trepel, Antonio C. Wolff, Joseph A. Sparano	76
12	Randomized controlled trial of cryotherapy to prevent paclitaxel-induced peripheral neuropathy (RU221511I); an ACCRU trial 2019 ·The Breast ·Kathryn J. Ruddy, Jennifer Le‐Rademacher, Mario E. Lacouture, Mary Wilkinson, Adedayo A. Onitilo, (unknown), (unknown), Travis Dockter, Angelina D. Tan, Andreas S. Beutler, Charles L. Loprinzi	38
13	Comparing Mammography Abnormality Features to Genetic Variants in the Prediction of Breast Cancer in Women Recommended for Breast Biopsy 2015 ·Academic Radiology ·Elizabeth S. Burnside, Jie Liu, Yirong Wu, Adedayo A. Onitilo, Catherine A. McCarty, C. David Page, Peggy Peissig, Amy Trentham‐Dietz, Terrie Kitchner, Jun Fan, Ming Yuan	10
14	Type 2 diabetes mellitus, glycemic control, and cancer risk 2013 ·European Journal of Cancer Prevention ·Adedayo A. Onitilo, Rachel V. Stankowski, (unknown), Jessica M. Engel, Ingrid Glurich, Gail Williams, Suhail A.R. Doi	59
15	Utilization of HER2 genetic testing in a multi-institutional observational study. 2012 ·PubMed ·Katrina A.B. Goddard, Erin J. Aiello Bowles, Heather Spencer Feigelson, Laurel A. Habel, Sharon Hensley Alford, Catherine A. McCarty, Larissa Nekhlyudov, Adedayo A. Onitilo, Alanna Kulchak Rahm, Jennifer Webster	12
16	Diabetes and cancer II: role of diabetes medications and influence of shared risk factors 2012 ·Cancer Causes & Control ·Adedayo A. Onitilo, Jessica M. Engel, Ingrid Glurich, Rachel V. Stankowski, Gail Williams, Suhail A.R. Doi	68
17	Risk of Heart Failure in Breast Cancer Patients After Anthracycline and Trastuzumab Treatment: A Retrospective Cohort Study breakdown → 2012 ·JNCI Journal of the National Cancer Institute ·Erin J. Aiello Bowles, Robert Wellman, Heather Spencer Feigelson, Adedayo A. Onitilo, Andrew N. Freedman, Thomas Delate, Larry A. Allen, Larissa Nekhlyudov, Katrina A.B. Goddard, Robert L. Davis, Laurel A. Habel, Marianne Ulcickas Yood, Catherine A. McCarty, David J. Magid, Edward H. Wagner, (unknown)	411
18	Performance of Claims-based Algorithms for Identifying Heart Failure and Cardiomyopathy Among Patients Diagnosed With Breast Cancer 2012 ·Medical Care ·Larry A. Allen, Marianne Ulcickas Yood, Edward H. Wagner, Erin J. Aiello Bowles, Roy Pardee, Robert Wellman, Laurel A. Habel, Larissa Nekhlyudov, Robert L. Davis, Adedayo A. Onitilo, David J. Magid	26
19	Adjuvant therapy for HER2+ breast cancer: practice, perception, and toxicity 2011 ·Breast Cancer Research and Treatment ·Gabrielle B. Rocque, Adedayo A. Onitilo, Jessica M. Engel, (unknown), (unknown), KyungMann Kim, (unknown), (unknown), Kari B. Wisinski, Amyé Tevaarwerk, Mark E. Burkard	14
20	Community experience with bortezomib in patients with multiple myeloma 2007 ·American Journal of Hematology ·Adedayo A. Onitilo, Jessica M. Engel, Bankole Olatosi, (unknown)	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact